B. Riley Securities Reiterates Buy on Precigen, Lowers Price Target to $11
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsReiterationPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
B. Riley Securities analyst Yuan Zhi reiterates Precigen (NASDAQ:PGEN) with a Buy and lowers the price target from $12 to $11.
B. Riley Securities analyst Yuan Zhi reiterates Precigen (NASDAQ:PGEN) with a Buy and lowers the price target from $12 to $11.
